InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,996.66
(
1.00%
)
US TECH 100
20,877.20
(
1.72%
)
Dow Jones
43,487.83
(
0.78%
)
Brent Oil
80.01
(
0.00%
)
Bitcoin
104,461.68
(
0.04%
)
Post# of 254335
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 121033
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 186999

Wednesday, 02/04/2015 12:03:09 PM

Wednesday, February 04, 2015 12:03:09 PM

Post# of 254335

What about BMY's BTD for Daclatasvir + asunaprevir + BMS-791325? I assume it will be rescinded as well.

It may be moot insofar as BMY made no statement about submitting an NDA for this 3-DAA regimen on its 4Q14 CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up